Hyaluronic Acid Market by Application, End-user, and Geography - Forecast and Analysis 2023-2027

Published: Mar 2023 Pages: 162 SKU: IRTNTR75120

The hyaluronic acid market size is estimated to grow at a CAGR of 7.3% between 2022 and 2027. The hyaluronic acid market size is forecast to increase by USD 3,719.76 million. The market's growth depends on several factors, such as the need for safe and stable drugs that require minimal monitoring, growing investments in expanding production facilities and increasing health consciousness among people.

This hyaluronic acid market report extensively covers market segmentation by application (dermal fillers, osteoarthritis, ophthalmic, and vesicoureteral reflux), end-user (pharmaceutical industry and cosmetic industry), and geography (North America, APAC, Europe, Middle East and Africa, and South America). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.

What will be the Size of the Hyaluronic Acid Market During the Forecast Period?

To learn more about this report, View Report Sample

Hyaluronic Acid Market: Key Drivers, Trends, Challenges, and Customer Landscape

The need for safe and stable drugs that require minimal monitoring is notably driving the market growth, although factors such as fluctuating raw material prices may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Hyaluronic Acid Market Driver

The huge requirement for safe and stable drugs that require minimal monitoring is the key factor driving the growth of the global hyaluronic acid market. Most drugs used to treat dermatologic conditions are associated with neuropsychiatric side effects. Because they are dose and duration-dependent and hence require systematic monitoring to identify adverse effects. Rational drug use is conventionally defined as the use of appropriate, effective, safe, and cost-effective treatments in recommended dosages and formulations for appropriate indications and for the required duration. Rational prescription by the dermatologist involves defining the illness, specifying therapy objectives, using personalized treatment, initiating treatment, providing information to patients, and monitoring the patient.

Since most available dermatological drugs require repeated and long-term use, the term rational prescription may not be valid. The stability of most dermatological drugs also varies depending on the climate. For instance, extreme climatic conditions can reduce the potency of drugs, with some drugs degrading faster than others. Hence, there is a need for drugs that show sufficient chemical, physical, and microbial stability in varied climatic conditions. Such an increase in demand for HA-based dermatological drugs, in turn, is expected to drive the growth of the global HA market.

Significant Hyaluronic Acid Market Trends

Increasing acquisitions and joint ventures is the primary trend in the global hyaluronic acid market. Regional and global players are operating in the global HA market by forming strategic alliances and partnerships. The manufacturer has expanded its product portfolio through strategic alliances to meet the growing demand for HA from pharmaceutical industries such as dermatology, orthopedics, and surgical adhesion prevention. For instance, in March 2022, AbbVie Inc. acquired Syndesi Therapeutics to expand AbbVie's neuroscience portfolio. AbbVie now has access to Syndesi's portfolio of new modulators of the synaptic vesicle protein 2A (SV2A), including its flagship product SDI-118.

The mechanism is now being studied for its possible application in the treatment of cognitive impairment and other symptoms associated with a variety of neuropsychiatric and neurodegenerative illnesses, including Alzheimer's disease and major depressive disorder. Such M&A activities help vendors to expand their product portfolios and geographical presence and enhance product development, which will boost the growth of the global HA market during the forecast period.

Major Hyaluronic Acid Market Challenge

Rising raw material prices are a major challenge to the growth of the global hyaluronic acid market. Producing HA requires raw materials such as essential oils, plant extracts, chemicals, syrups, and vitamins. HA comes from natural plant-based sources such as soybeans and wheat, and it also comes from animal sources such as rooster combs. In addition, raw materials such as essential oils and plant extracts are being used more and more in various products such as pharmaceuticals and cosmetics, resulting in rising prices in Europe and the United States. 

Thus, the cost of production incurred by HA manufacturers is increasing because manufacturers from other industries are also procuring the raw materials. This will negatively impact the profit margins of the vendors, and as a result, vendors are increasing the prices of their offerings. Such factors are expected to negatively impact the growth of the global HA market during the forecast period.

Key Hyaluronic Acid Market Customer Landscape

The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Hyaluronic Acid Market Customer Landscape

Who are the Major Hyaluronic Acid Market Vendors?

Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

AbbVie Inc.: The company offers hyaluronic acids such as JUVEDERM VOLUX XC. Also, the company conducts research and development, manufacturing, commercialization, and sale of innovative medicines and therapies to allocate resources and assess business performance on a global basis in order to achieve established long-term strategic goals.

The report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:

  • ABDI Ibrahim ILAC Sanayi Ve Ticaret Anonim Sirke
  • Anika Therapeutics Inc.
  • Bausch Health Co. Inc.
  • Bioxis Pharmaceutical
  • Bloomage Biotechnology Corp Ltd.
  • Ferring BV
  • Fidia Farmaceutici Spa
  • Galderma SA
  • Huadong Medicine Co. Ltd.
  • Laboratoires VIVACY SAS
  • LG Chem Ltd.
  • Merz Pharma GmbH and Co KGaA
  • Sanofi SA
  • Smith and Nephew plc
  • Teva Pharmaceutical Industries Ltd.

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

What is the Fastest-Growing Segments in the Hyaluronic Acid Market?

The market share growth by the dermal fillers segment will be significant during the forecast period. The use of HA dermal fillers is to restore the lost tissue volume, giving sagging skin an elastic aspect and a fuller appearance. Moreover, the cross-linked HA particles used in fillers provide a concentrated material that is resistant to many types of physical and chemical disintegration. Such factors will increase segment growth during the forecast period.

Get a glance at the market contribution of various segments View the PDF Sample

The dermal fillers segment was valued at USD 3,416.24 million in 2017 and continued to grow until 2021. In recent years, the pool of patients adversely affected by dermatologic conditions has greatly expanded due to major factors such as poor nutrition, stress, environmental pollution, unhealthy eating habits, and weakened immunity. This has increased the demand for effective treatments and medicines for dermatological diseases. HA preparations come in oral, topically applied, and injectable forms and have received Food and Drug Administration (FDA) approval for several of them. HA has become widely used in cosmetic injections in recent years due to its capacity to reduce the visibility of wrinkles and other aging-related skin defects. Therefore, the growth of the dermal filler segment is expected to contribute to the growth of the global HA market during the forecast period. 

Which are the Key Regions for the Hyaluronic Acid Market?

For more insights on the market share of various regions Download PDF Sample now!

North America is estimated to contribute 36% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The North American HA market is experiencing significant growth, primarily due to an aging population and high prevalence of chronic and infectious skin diseases. This has increased the demand for dermatology medicines and services in the region, increasing the demand for HA acids. Especially in the US, the growing awareness about diagnostic dermatology tests among the geriatric population has increased the sales of dermatological drugs in the country.

The COVID-19 pandemic negatively impacted the HA market in the region during 2020-2021. However, the initiation of large-scale COVID-19 vaccination drives in 2021 and the subsequent lifting of lockdown restrictions led to the gradual resumption of operations at manufacturing and logistics units for HA, which eased research and development (R&D) related constraints. With the gradual decline in the number of COVID-19 cases, the situation has returned to normalcy, and hence, pragmatic action is required to deal with the challenges faced by dermatologic and orthopedic patients with respect to the continuous availability of dermatological drugs at hospitals or clinics in 2022. Thus, the gradually improving economic situation in North America is expected to increase the demand for HA, which, in turn, is expected to fuel the regional HA market during the forecast period.

Segment Overview

The hyaluronic acid market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • Application Outlook (USD Million, 2017 - 2027)
    • Dermal fillers
    • Osteoarthritis
    • Ophthalmic
    • Vesicoureteral reflux
  • End-user Outlook (USD Million, 2017 - 2027)
    • Pharmaceutical industry
    • Cosmetic industry
  • Region Outlook (USD Million, 2017 - 2027)
    • North America
      • The U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Rest of Europe
    • APAC
      • China
      • India
    • South America
      • Chile
      • Argentona
      • brazil
    • Middle East & Africa
      • Saudi Arabia
      • South Africa
      • Rest of the Middle East & Africa

Parent Market Analysis

Technavio categorizes the global hyaluronic acid (HA) market as a part of the global specialty chemicals market within the global chemicals market. The parent global chemicals market covers companies engaged in the manufacturing of various types of products under organic and inorganic chemicals. Our market research report has extensively covered external factors influencing the parent market growth during the forecast period.

Hyaluronic Acid Market Scope

Report Coverage

Details

Page number

162

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 7.3%

Market growth 2023-2027

USD 3,719.76 million

Market structure

Fragmented

YoY growth 2022-2023(%)

6.6

Regional analysis

North America, APAC, Europe, Middle East and Africa, and South America

Performing market contribution

North America at 36%

Key countries

US, Canada, China, South Korea, and Germany

Competitive landscape

 Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

AbbVie Inc., ABDI Ibrahim ILAC Sanayi Ve Ticaret Anonim Sirke, Anika Therapeutics Inc., Bausch Health Co. Inc., Bioplus Co. Ltd., BioScience GmbH Cosmetics Trading LLC, Bioxis Pharmaceutical, Bloomage Biotechnology Corp Ltd., Ferring BV, Fidia Farmaceutici Spa, Galderma SA, Huadong Medicine Co. Ltd., Laboratoires VIVACY SAS, LG Chem Ltd., Merz Pharma GmbH and Co KGaA, Sanofi SA, Seikagaku Corp., Smith and Nephew plc, SyrHA Trading SA, Teva Pharmaceutical Industries Ltd., and Zimmer Biomet Holdings Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View the PDF sample

What are the Key Data Covered in this Hyaluronic Acid Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the hyaluronic acid market between 2023 and 2027
  • Precise estimation of the size of the hyaluronic acid market size and its contribution of the market in focus to the parent market
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market industry across North America, APAC, Europe, Middle East and Africa, and South America
  • Thorough analysis of the market’s competitive landscape and detailed information about vendors
  • Comprehensive analysis of factors that will challenge the growth of hyaluronic acid market vendors

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global hyaluronic acid market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on Global hyaluronic acid market 2017 - 2021 ($ million)
    • 4.2 Application Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Application Segment 2017 - 2021 ($ million)
    • 4.3 End-users Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – End-users Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Application

    • 6.1 Market segments
      • Exhibit 30: Chart on Application - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
    • 6.2 Comparison by Application
      • Exhibit 32: Chart on Comparison by Application
      • Exhibit 33: Data Table on Comparison by Application
    • 6.3 Dermal fillers - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Dermal fillers - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Dermal fillers - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Dermal fillers - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Dermal fillers - Year-over-year growth 2022-2027 (%)
    • 6.4 Osteoarthritis - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Osteoarthritis - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Osteoarthritis - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Osteoarthritis - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Osteoarthritis - Year-over-year growth 2022-2027 (%)
    • 6.5 Ophthalmic - Market size and forecast 2022-2027
      • Exhibit 42: Chart on Ophthalmic - Market size and forecast 2022-2027 ($ million)
      • Exhibit 43: Data Table on Ophthalmic - Market size and forecast 2022-2027 ($ million)
      • Exhibit 44: Chart on Ophthalmic - Year-over-year growth 2022-2027 (%)
      • Exhibit 45: Data Table on Ophthalmic - Year-over-year growth 2022-2027 (%)
    • 6.6 Vesicoureteral reflux - Market size and forecast 2022-2027
      • Exhibit 46: Chart on Vesicoureteral reflux - Market size and forecast 2022-2027 ($ million)
      • Exhibit 47: Data Table on Vesicoureteral reflux - Market size and forecast 2022-2027 ($ million)
      • Exhibit 48: Chart on Vesicoureteral reflux - Year-over-year growth 2022-2027 (%)
      • Exhibit 49: Data Table on Vesicoureteral reflux - Year-over-year growth 2022-2027 (%)
    • 6.7 Market opportunity by Application
      • Exhibit 50: Market opportunity by Application ($ million)
      • Exhibit 51: Data Table on Market opportunity by Application ($ million)

    7 Market Segmentation by End-user

    • 7.1 Market segments
      • Exhibit 52: Chart on End-user - Market share 2022-2027 (%)
      • Exhibit 53: Data Table on End-user - Market share 2022-2027 (%)
    • 7.2 Comparison by End-user
      • Exhibit 54: Chart on Comparison by End-user
      • Exhibit 55: Data Table on Comparison by End-user
    • 7.3 Pharmaceutical industry - Market size and forecast 2022-2027
      • Exhibit 56: Chart on Pharmaceutical industry - Market size and forecast 2022-2027 ($ million)
      • Exhibit 57: Data Table on Pharmaceutical industry - Market size and forecast 2022-2027 ($ million)
      • Exhibit 58: Chart on Pharmaceutical industry - Year-over-year growth 2022-2027 (%)
      • Exhibit 59: Data Table on Pharmaceutical industry - Year-over-year growth 2022-2027 (%)
    • 7.4 Cosmetic industry - Market size and forecast 2022-2027
      • Exhibit 60: Chart on Cosmetic industry - Market size and forecast 2022-2027 ($ million)
      • Exhibit 61: Data Table on Cosmetic industry - Market size and forecast 2022-2027 ($ million)
      • Exhibit 62: Chart on Cosmetic industry - Year-over-year growth 2022-2027 (%)
      • Exhibit 63: Data Table on Cosmetic industry - Year-over-year growth 2022-2027 (%)
    • 7.5 Market opportunity by End-user
      • Exhibit 64: Market opportunity by End-user ($ million)
      • Exhibit 65: Data Table on Market opportunity by End-user ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 67: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 68: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 69: Chart on Geographic comparison
      • Exhibit 70: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 APAC - Market size and forecast 2022-2027
      • Exhibit 75: Chart on APAC - Market size and forecast 2022-2027 ($ million)
      • Exhibit 76: Data Table on APAC - Market size and forecast 2022-2027 ($ million)
      • Exhibit 77: Chart on APAC - Year-over-year growth 2022-2027 (%)
      • Exhibit 78: Data Table on APAC - Year-over-year growth 2022-2027 (%)
    • 9.5 Europe - Market size and forecast 2022-2027
      • Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.6 Middle East and Africa - Market size and forecast 2022-2027
      • Exhibit 83: Chart on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
      • Exhibit 84: Data Table on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
      • Exhibit 85: Chart on Middle East and Africa - Year-over-year growth 2022-2027 (%)
      • Exhibit 86: Data Table on Middle East and Africa - Year-over-year growth 2022-2027 (%)
    • 9.7 South America - Market size and forecast 2022-2027
      • Exhibit 87: Chart on South America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 88: Data Table on South America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 89: Chart on South America - Year-over-year growth 2022-2027 (%)
      • Exhibit 90: Data Table on South America - Year-over-year growth 2022-2027 (%)
    • 9.8 US - Market size and forecast 2022-2027
      • Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.9 Canada - Market size and forecast 2022-2027
      • Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
    • 9.10 China - Market size and forecast 2022-2027
      • Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.11 South Korea - Market size and forecast 2022-2027
      • Exhibit 103: Chart on South Korea - Market size and forecast 2022-2027 ($ million)
      • Exhibit 104: Data Table on South Korea - Market size and forecast 2022-2027 ($ million)
      • Exhibit 105: Chart on South Korea - Year-over-year growth 2022-2027 (%)
      • Exhibit 106: Data Table on South Korea - Year-over-year growth 2022-2027 (%)
    • 9.12 Germany - Market size and forecast 2022-2027
      • Exhibit 107: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 108: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 109: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 110: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.13 Market opportunity by geography
      • Exhibit 111: Market opportunity by geography ($ million)
      • Exhibit 112: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 113: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 115: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 116: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 117: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 118: Matrix on vendor position and classification
            • 12.3 AbbVie Inc.
              • Exhibit 119: AbbVie Inc. - Overview
              • Exhibit 120: AbbVie Inc. - Product / Service
              • Exhibit 121: AbbVie Inc. - Key news
              • Exhibit 122: AbbVie Inc. - Key offerings
            • 12.4 ABDI Ibrahim ILAC Sanayi Ve Ticaret Anonim Sirke
              • Exhibit 123: ABDI Ibrahim ILAC Sanayi Ve Ticaret Anonim Sirke - Overview
              • Exhibit 124: ABDI Ibrahim ILAC Sanayi Ve Ticaret Anonim Sirke - Product / Service
              • Exhibit 125: ABDI Ibrahim ILAC Sanayi Ve Ticaret Anonim Sirke - Key news
              • Exhibit 126: ABDI Ibrahim ILAC Sanayi Ve Ticaret Anonim Sirke - Key offerings
            • 12.5 Anika Therapeutics Inc.
              • Exhibit 127: Anika Therapeutics Inc. - Overview
              • Exhibit 128: Anika Therapeutics Inc. - Product / Service
              • Exhibit 129: Anika Therapeutics Inc. - Key offerings
            • 12.6 Bausch Health Co. Inc.
              • Exhibit 130: Bausch Health Co. Inc. - Overview
              • Exhibit 131: Bausch Health Co. Inc. - Business segments
              • Exhibit 132: Bausch Health Co. Inc. - Key news
              • Exhibit 133: Bausch Health Co. Inc. - Key offerings
              • Exhibit 134: Bausch Health Co. Inc. - Segment focus
            • 12.7 Bioxis Pharmaceutical
              • Exhibit 135: Bioxis Pharmaceutical - Overview
              • Exhibit 136: Bioxis Pharmaceutical - Product / Service
              • Exhibit 137: Bioxis Pharmaceutical - Key offerings
            • 12.8 Bloomage Biotechnology Corp Ltd.
              • Exhibit 138: Bloomage Biotechnology Corp Ltd. - Overview
              • Exhibit 139: Bloomage Biotechnology Corp Ltd. - Product / Service
              • Exhibit 140: Bloomage Biotechnology Corp Ltd. - Key offerings
            • 12.9 Ferring BV
              • Exhibit 141: Ferring BV - Overview
              • Exhibit 142: Ferring BV - Product / Service
              • Exhibit 143: Ferring BV - Key offerings
            • 12.10 Fidia Farmaceutici Spa
              • Exhibit 144: Fidia Farmaceutici Spa - Overview
              • Exhibit 145: Fidia Farmaceutici Spa - Product / Service
              • Exhibit 146: Fidia Farmaceutici Spa - Key offerings
            • 12.11 Galderma SA
              • Exhibit 147: Galderma SA - Overview
              • Exhibit 148: Galderma SA - Product / Service
              • Exhibit 149: Galderma SA - Key news
              • Exhibit 150: Galderma SA - Key offerings
            • 12.12 LG Chem Ltd.
              • Exhibit 151: LG Chem Ltd. - Overview
              • Exhibit 152: LG Chem Ltd. - Business segments
              • Exhibit 153: LG Chem Ltd. - Key news
              • Exhibit 154: LG Chem Ltd. - Key offerings
              • Exhibit 155: LG Chem Ltd. - Segment focus
            • 12.13 Merz Pharma GmbH and Co KGaA
              • Exhibit 156: Merz Pharma GmbH and Co KGaA - Overview
              • Exhibit 157: Merz Pharma GmbH and Co KGaA - Product / Service
              • Exhibit 158: Merz Pharma GmbH and Co KGaA - Key offerings
            • 12.14 Sanofi SA
              • Exhibit 159: Sanofi SA - Overview
              • Exhibit 160: Sanofi SA - Business segments
              • Exhibit 161: Sanofi SA - Key news
              • Exhibit 162: Sanofi SA - Key offerings
              • Exhibit 163: Sanofi SA - Segment focus
            • 12.15 Smith and Nephew plc
              • Exhibit 164: Smith and Nephew plc - Overview
              • Exhibit 165: Smith and Nephew plc - Business segments
              • Exhibit 166: Smith and Nephew plc - Key news
              • Exhibit 167: Smith and Nephew plc - Key offerings
              • Exhibit 168: Smith and Nephew plc - Segment focus
            • 12.16 Teva Pharmaceutical Industries Ltd.
              • Exhibit 169: Teva Pharmaceutical Industries Ltd. - Overview
              • Exhibit 170: Teva Pharmaceutical Industries Ltd. - Business segments
              • Exhibit 171: Teva Pharmaceutical Industries Ltd. - Key news
              • Exhibit 172: Teva Pharmaceutical Industries Ltd. - Key offerings
              • Exhibit 173: Teva Pharmaceutical Industries Ltd. - Segment focus
            • 12.17 Zimmer Biomet Holdings Inc.
              • Exhibit 174: Zimmer Biomet Holdings Inc. - Overview
              • Exhibit 175: Zimmer Biomet Holdings Inc. - Business segments
              • Exhibit 176: Zimmer Biomet Holdings Inc. - Key news
              • Exhibit 177: Zimmer Biomet Holdings Inc. - Key offerings
              • Exhibit 178: Zimmer Biomet Holdings Inc. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 179: Inclusions checklist
                • Exhibit 180: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 181: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 182: Research methodology
                • Exhibit 183: Validation techniques employed for market sizing
                • Exhibit 184: Information sources
              • 13.5 List of abbreviations
                • Exhibit 185: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              hyaluronic acid market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis